Concepedia

Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours

Takashi Seto, Taito Esaki, Fumihiko Hirai, Shuji Arita, Kaname Nosaki, Akitaka Makiyama, Takuro Kometani, Chinatsu Fujimoto, Motoharu Hamatake, Hiroaki Takeoka,

Cancer Chemotherapy and Pharmacology · 2013 · 101 citations · 12 references

DOI

Concepts

References

12

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Aberrant cell cycle checkpoint function and early embryonic death in <i>Chk1</i><sup>−/−</sup> mice

Hiroyuki Takai, Kaoru Tominaga, Noboru Motoyama et al. · Genes & Development · 2000 · 469 citations · Full text

, , +17

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

Hideki Ueno, T Kosuge, Y Matsuyama et al. · British Journal of Cancer · 2009 · 440 citations · Full text

, , +14

AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies

Sonya Zabludoff, Chun Deng, Michael Grondine et al. · Molecular Cancer Therapeutics · 2008 · 410 citations · Full text

, , +17

Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Sorafenib in Japanese Patients with Advanced Renal Cell Carcinoma

Hideyuki Akaza, Tadashi Tsukamoto, Masaru Murai et al. · Japanese Journal of Clinical Oncology · 2007 · 152 citations

, , +15